Align Technology (ALGN) | Financial Analysis & Statements
Align Technology Inc. Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
1.0B
Gross Profit
683.6M
65.26%
Operating Income
158.9M
15.17%
Net Income
135.8M
12.96%
EPS (Diluted)
$1.89
Balance Sheet Metrics
Total Assets
6.2B
Total Liabilities
2.2B
Shareholders Equity
4.0B
Debt to Equity
0.54
Cash Flow Metrics
Operating Cash Flow
294.2M
Free Cash Flow
187.3M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Align Technology Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 4.0B | 4.0B | 3.9B | 3.7B | 4.0B |
| Cost of Goods Sold | 1.3B | 1.2B | 1.2B | 1.1B | 1.0B |
| Gross Profit | 2.7B | 2.8B | 2.7B | 2.6B | 2.9B |
| Gross Margin % | 67.2% | 70.0% | 70.1% | 70.5% | 74.3% |
| Operating Expenses | |||||
| Research & Development | 369.9M | 364.2M | 346.8M | 305.3M | 250.3M |
| Selling, General & Administrative | 1.8B | 1.8B | 1.7B | 1.7B | 1.7B |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 2.1B | 2.1B | 2.1B | 2.0B | 2.0B |
| Operating Income | 585.3M | 671.8M | 656.7M | 654.0M | 976.4M |
| Operating Margin % | 14.5% | 16.8% | 17.0% | 17.5% | 24.7% |
| Non-Operating Items | |||||
| Interest Income | 16.0M | 20.2M | 17.3M | 5.4M | 3.1M |
| Interest Expense | - | - | - | - | - |
| Other Non-Operating Income | -16.1M | -83.0M | -32.7M | -60.4M | 32.9M |
| Pre-tax Income | 585.3M | 609.0M | 641.2M | 599.1M | 1.0B |
| Income Tax | 174.9M | 187.6M | 196.2M | 237.5M | 240.4M |
| Effective Tax Rate % | 29.9% | 30.8% | 30.6% | 39.6% | 23.7% |
| Net Income | 410.4M | 421.4M | 445.1M | 361.6M | 772.0M |
| Net Margin % | 10.2% | 10.5% | 11.5% | 9.7% | 19.5% |
| Key Metrics | |||||
| EBITDA | 862.3M | 880.9M | 812.4M | 791.3M | 1.1B |
| EPS (Basic) | $5.66 | $5.63 | $5.82 | $4.62 | $9.78 |
| EPS (Diluted) | $5.65 | $5.62 | $5.81 | $4.61 | $9.69 |
| Basic Shares Outstanding | 72542000 | 74877000 | 76426000 | 78190000 | 78917000 |
| Diluted Shares Outstanding | 72542000 | 74877000 | 76426000 | 78190000 | 78917000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Align Technology Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 1.1B | 1.0B | 937.4M | 942.0M | 1.1B |
| Short-term Investments | - | 0 | 35.3M | 57.5M | 72.0M |
| Accounts Receivable | 1.1B | 995.7M | 903.4M | 859.7M | 897.2M |
| Inventory | 226.3M | 254.3M | 296.9M | 338.8M | 230.2M |
| Other Current Assets | 47.3M | 81.6M | 77.3M | 16.8M | 31.5M |
| Total Current Assets | 2.6B | 2.5B | 2.4B | 2.4B | 2.5B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 956.8M | 985.2M | 821.8M | 702.7M | 574.1M |
| Goodwill | 1.1B | 988.7M | 921.2M | 910.8M | 946.8M |
| Intangible Assets | 93.9M | 103.5M | 82.1M | 95.7M | 109.7M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 1.8B | 1.8B | 1.7B | 1.6B | 1.6B |
| Total Non-Current Assets | 3.6B | 3.7B | 3.6B | 3.5B | 3.4B |
| Total Assets | 6.2B | 6.2B | 6.1B | 5.9B | 5.9B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 121.4M | 108.7M | 113.1M | 127.9M | 163.9M |
| Short-term Debt | 31.9M | 31.1M | 29.7M | 26.6M | 22.7M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 1.9B | 2.0B | 2.1B | 1.9B | 1.9B |
| Non-Current Liabilities | |||||
| Long-term Debt | 82.5M | 88.2M | 97.0M | 100.3M | 102.7M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 113.8M | 139.9M | 173.1M | 196.0M | 174.6M |
| Total Non-Current Liabilities | 264.5M | 324.6M | 386.8M | 420.7M | 395.3M |
| Total Liabilities | 2.2B | 2.4B | 2.5B | 2.3B | 2.3B |
| Equity | |||||
| Common Stock | 7.0K | 7.0K | 7.0K | 8.0K | 8.0K |
| Retained Earnings | 2.5B | 2.5B | 2.4B | 2.6B | 2.6B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 4.0B | 3.9B | 3.6B | 3.6B | 3.6B |
| Key Metrics | |||||
| Total Debt | 114.4M | 119.3M | 126.6M | 126.9M | 125.4M |
| Working Capital | 696.5M | 454.4M | 380.0M | 498.5M | 570.0M |
Balance Sheet Composition
Align Technology Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 410.4M | 421.4M | 445.1M | 361.6M | 772.0M |
| Depreciation & Amortization | 237.4M | 145.0M | 142.4M | 125.8M | 108.7M |
| Stock-Based Compensation | 185.9M | 173.7M | 154.0M | 133.4M | 114.3M |
| Working Capital Changes | -245.5M | -209.4M | 4.6M | 96.8M | 107.9M |
| Operating Cash Flow | 698.6M | 607.2M | 793.2M | 749.9M | 1.2B |
| Investing Activities | |||||
| Capital Expenditures | -102.4M | -115.6M | -177.7M | -291.9M | -401.1M |
| Acquisitions | -10.0M | -183.4M | -77.0M | -12.3M | -8.0M |
| Investment Purchases | 0 | 0 | -2.9M | -28.0M | -200.9M |
| Investment Sales | 0 | 43.9M | 61.4M | 121.1M | 47.0M |
| Investing Cash Flow | -112.4M | -254.9M | -195.9M | -213.3M | -563.4M |
| Financing Activities | |||||
| Share Repurchases | -465.9M | -352.9M | -592.4M | -435.0M | -375.0M |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | - | - | - | - | 0 |
| Financing Cash Flow | -464.6M | -355.7M | -598.3M | -501.7M | -458.3M |
| Free Cash Flow | 490.8M | 622.7M | 608.1M | 276.8M | 771.4M |
| Net Change in Cash | 121.6M | -3.5M | -1.0M | 34.9M | 147.8M |
Cash Flow Trend
Align Technology Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
34.70
Forward P/E
15.92
Price to Book
3.46
Price to Sales
3.48
PEG Ratio
0.96
Profitability Ratios
Profit Margin
10.17%
Operating Margin
22.38%
Return on Equity
10.39%
Return on Assets
6.94%
Financial Health
Current Ratio
1.36
Debt to Equity
2.83
Beta
1.81
Per Share Data
EPS (TTM)
$5.65
Book Value per Share
$56.74
Revenue per Share
$55.62
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ALGN | 13.7B | 34.70 | 3.46 | 10.39% | 10.17% | 2.83 |
| Intuitive Surgical | 170.1B | 54.97 | 8.99 | 16.69% | 28.38% | 0.95 |
| Becton, Dickinson | 56.1B | 25.40 | 1.75 | 6.96% | 8.01% | 77.28 |
| Alcon | 45.8B | 40.84 | 2.07 | 5.23% | 11.28% | 23.63 |
| ResMed | 32.0B | 21.69 | 5.06 | 25.68% | 27.53% | 13.41 |
| West Pharmaceutical | 22.1B | 40.99 | 6.94 | 19.13% | 16.85% | 10.73 |
Financial data is updated regularly. All figures are in the company's reporting currency.






